_id
690db09dccc777a4e85d0b94
Ticker
ARGX
Name
argenx NV ADR
Exchange
NASDAQ
Address
Laarderhoogtweg 25, Amsterdam, Netherlands, 1101 EB
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://argenx.com
Description
argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYGART and VYGART HYTRULO to treat generalized myasthenia gravis (gMG), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgartigimod for the treatment of seronegative and ocular gMG, thyroid eye diseases, ITP, myositis, Sjögren's disease, lupus nephropathy, systemic sclerosis, antibody-mediated rejection, and autoimmune encephalitis; empasiprubart for multifocal motor neuropath, CIDP, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome, amyotrophic lateral sclerosis, and spinal muscular atrophy. In addition, the company is also developing ARGX-119, a MuSK agonist to treat congenital myasthenic syndromes and amyotrophic lateral sclerosis; ARGX-109, which targets IL-6 to treat inflammation; ARGX-121 and ARGX 220 that targets the immune system; ARGX-213, which targets FcRn; and ARGX-118, which develops antibodies against Galectin-10, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It has strategic collaborations with OncoVerity, Inc, LEO Pharma A/S, Zai Lab Limited, AbbVie, Inc., Elektrofi, Genmab SE, Chugai Pharmaceutical Co., Ltd., Clayton Foundation, Halozyme Therapeutics, Inc., AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Lonza Sales AG, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, and IQVIA Ltd. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.
Last Close
802.66
Volume
392576
Current Price
816.37
Change
6.73
Last Updated
2026-01-22T10:29:07.626Z
Image
data:image/webp;base64,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
Ipo Date
2017-05-18T00:00:00.000Z
Market Cap
50519756800
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.68299375
Sentiment Sources
16
Rating
4.5909
Target Price
1016.4751
Strong Buy
14
Buy
7
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
1126961000
Cost Of Revenue
109426000
Gross Profit
1017535000
Operating Expenses
776991000
Operating Income
349970000
Interest Expense
993000
Pretax Income
386053000
Net Income
344258000
Eps
-
Dividends Per Share
-
Shares Outstanding
61883406
Income Tax Expense
-
EBITDA
-
Operating Margin
31.05431332583825
Total Other Income Expense Net
-5624000
Cash
-
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
-
Property Plant Equipment
-
Total Assets
-
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
-
Equity
-
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
USD
PE
34.9473
PB
-
ROE
-
ROA
-
FCF
-
Fcf Percent
-
Piotroski FScore
1
Health Score
46
Deep Value Investing Score
1
Defensive Investing Score
3
Dividend Investing Score
1.5
Economic Moat Investing Score
6
Garp Investing Score
1.5
Growth Investing Score
1.5
Momentum Investing Score
7.5
Net Net Investing Score
0
Quality Investing Score
4
Value Investing Score
1
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1126961000
Quarters > 0 > income Statement > cost Of Revenue
109426000
Quarters > 0 > income Statement > gross Profit
1017535000
Quarters > 0 > income Statement > operating Expenses
776991000
Quarters > 0 > income Statement > operating Income
349970000
Quarters > 0 > income Statement > interest Expense
993000
Quarters > 0 > income Statement > pretax Income
386053000
Quarters > 0 > income Statement > net Income
344258000
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
31.05431332583825
Quarters > 0 > income Statement > total Other Income Expense Net
-5624000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
-
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
344258000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
46
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
947961000
Quarters > 1 > income Statement > cost Of Revenue
110747000
Quarters > 1 > income Statement > gross Profit
837214000
Quarters > 1 > income Statement > operating Expenses
636153000
Quarters > 1 > income Statement > operating Income
201061000
Quarters > 1 > income Statement > interest Expense
1126000
Quarters > 1 > income Statement > pretax Income
286899000
Quarters > 1 > income Statement > net Income
245358000
Quarters > 1 > income Statement > eps
3.7371936368428638
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
65653007
Quarters > 1 > income Statement > income Tax Expense
41541000
Quarters > 1 > income Statement > EBITDA
513953796
Quarters > 1 > income Statement > operating Margin
21.20983880138529
Quarters > 1 > income Statement > total Other Income Expense Net
85838000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2085976000
Quarters > 1 > balance Sheet > short Term Investments
1842200000
Quarters > 1 > balance Sheet > receivables
1198226000
Quarters > 1 > balance Sheet > inventories
340621000
Quarters > 1 > balance Sheet > total Current Assets
5829739000
Quarters > 1 > balance Sheet > property Plant Equipment
45795000
Quarters > 1 > balance Sheet > total Assets
7175592000
Quarters > 1 > balance Sheet > payables
531969000
Quarters > 1 > balance Sheet > short Term Debt
7584000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1079840000
Quarters > 1 > balance Sheet > equity
6095752000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
418148729
Quarters > 1 > cash Flow > depreciation
13369203
Quarters > 1 > cash Flow > change In Working Capital
-129208418
Quarters > 1 > cash Flow > cash From Operations
437854268
Quarters > 1 > cash Flow > capital Expenditures
5248698
Quarters > 1 > cash Flow > cash From Investing
-10307884
Quarters > 1 > cash Flow > cash From Financing
74078471
Quarters > 1 > cash Flow > net Change In Cash
586040000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
3.7371936368428638
Quarters > 1 > ratios > PB
8.792540333758657
Quarters > 1 > ratios > ROE
4.025065324179855
Quarters > 1 > ratios > ROA
3.419341567915233
Quarters > 1 > ratios > FCF
432605570
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.4563537634987093
Quarters > 1 > health Score
68
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
790683000
Quarters > 2 > income Statement > cost Of Revenue
80805000
Quarters > 2 > income Statement > gross Profit
709878000
Quarters > 2 > income Statement > operating Expenses
570938000
Quarters > 2 > income Statement > operating Income
138940000
Quarters > 2 > income Statement > interest Expense
1135000
Quarters > 2 > income Statement > pretax Income
202361000
Quarters > 2 > income Statement > net Income
169469000
Quarters > 2 > income Statement > eps
2.580850999025341
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
65664000
Quarters > 2 > income Statement > income Tax Expense
32892000
Quarters > 2 > income Statement > EBITDA
203496000
Quarters > 2 > income Statement > operating Margin
17.57214964783611
Quarters > 2 > income Statement > total Other Income Expense Net
63421000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
149319140
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
2.580850999025341
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
54
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1346264000
Quarters > 3 > income Statement > cost Of Revenue
664896000
Quarters > 3 > income Statement > gross Profit
681368000
Quarters > 3 > income Statement > operating Expenses
562714000
Quarters > 3 > income Statement > operating Income
117228000
Quarters > 3 > income Statement > interest Expense
704000
Quarters > 3 > income Statement > pretax Income
174533000
Quarters > 3 > income Statement > net Income
865571000
Quarters > 3 > income Statement > eps
12.198872524839688
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
70955000
Quarters > 3 > income Statement > income Tax Expense
-687652000
Quarters > 3 > income Statement > EBITDA
126612000
Quarters > 3 > income Statement > operating Margin
8.707653179465543
Quarters > 3 > income Statement > total Other Income Expense Net
57305000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1499936000
Quarters > 3 > balance Sheet > short Term Investments
1878890000
Quarters > 3 > balance Sheet > receivables
909096000
Quarters > 3 > balance Sheet > inventories
407233000
Quarters > 3 > balance Sheet > total Current Assets
4883103000
Quarters > 3 > balance Sheet > property Plant Equipment
43518000
Quarters > 3 > balance Sheet > total Assets
6202522000
Quarters > 3 > balance Sheet > payables
342228000
Quarters > 3 > balance Sheet > short Term Debt
6533000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
704239000
Quarters > 3 > balance Sheet > equity
5498283000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
865571000
Quarters > 3 > cash Flow > depreciation
8904000
Quarters > 3 > cash Flow > change In Working Capital
-393865000
Quarters > 3 > cash Flow > cash From Operations
41909000
Quarters > 3 > cash Flow > capital Expenditures
990000
Quarters > 3 > cash Flow > cash From Investing
-203835000
Quarters > 3 > cash Flow > cash From Financing
239685000
Quarters > 3 > cash Flow > net Change In Cash
61689000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
12.198872524839688
Quarters > 3 > ratios > PB
10.535204053701856
Quarters > 3 > ratios > ROE
15.742569089295694
Quarters > 3 > ratios > ROA
13.95514598739029
Quarters > 3 > ratios > FCF
40919000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.03039448429134256
Quarters > 3 > health Score
62
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2190231000
Annuals > 0 > income Statement > cost Of Revenue
227289000
Annuals > 0 > income Statement > gross Profit
1962942000
Annuals > 0 > income Statement > operating Expenses
1984596000
Annuals > 0 > income Statement > operating Income
-21654000
Annuals > 0 > income Statement > interest Expense
2219000
Annuals > 0 > income Statement > pretax Income
85180000
Annuals > 0 > income Statement > net Income
833040000
Annuals > 0 > income Statement > eps
12.780999723833196
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
65178000
Annuals > 0 > income Statement > income Tax Expense
-747860000
Annuals > 0 > income Statement > EBITDA
105171000
Annuals > 0 > income Statement > operating Margin
-0.9886628396730756
Annuals > 0 > income Statement > total Other Income Expense Net
106834000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1499936000
Annuals > 0 > balance Sheet > short Term Investments
1878890000
Annuals > 0 > balance Sheet > receivables
909096000
Annuals > 0 > balance Sheet > inventories
407233000
Annuals > 0 > balance Sheet > total Current Assets
4883103000
Annuals > 0 > balance Sheet > property Plant Equipment
43518000
Annuals > 0 > balance Sheet > total Assets
6202522000
Annuals > 0 > balance Sheet > payables
342228000
Annuals > 0 > balance Sheet > short Term Debt
6533000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
704239000
Annuals > 0 > balance Sheet > equity
5498283000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
833040000
Annuals > 0 > cash Flow > depreciation
17527000
Annuals > 0 > cash Flow > change In Working Capital
-324599000
Annuals > 0 > cash Flow > cash From Operations
-82747000
Annuals > 0 > cash Flow > capital Expenditures
68301000
Annuals > 0 > cash Flow > cash From Investing
-717594000
Annuals > 0 > cash Flow > cash From Financing
279759000
Annuals > 0 > cash Flow > net Change In Cash
-548908000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
12.780999723833196
Annuals > 0 > ratios > PB
9.677450916949892
Annuals > 0 > ratios > ROE
15.150911657330116
Annuals > 0 > ratios > ROA
13.430665784014954
Annuals > 0 > ratios > FCF
-151048000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-0.06896441516899358
Annuals > 0 > health Score
60
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1226316000
Annuals > 1 > income Statement > cost Of Revenue
117835000
Annuals > 1 > income Statement > gross Profit
1108481000
Annuals > 1 > income Statement > operating Expenses
1533530000
Annuals > 1 > income Statement > operating Income
-425049000
Annuals > 1 > income Statement > interest Expense
904000
Annuals > 1 > income Statement > pretax Income
-304496000
Annuals > 1 > income Statement > net Income
-295053000
Annuals > 1 > income Statement > eps
-5.161066312162186
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
57169000
Annuals > 1 > income Statement > income Tax Expense
-9443000
Annuals > 1 > income Statement > EBITDA
-192285000
Annuals > 1 > income Statement > operating Margin
-34.660642118344704
Annuals > 1 > income Statement > total Other Income Expense Net
120553000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
2048844000
Annuals > 1 > balance Sheet > short Term Investments
1131000000
Annuals > 1 > balance Sheet > receivables
499271000
Annuals > 1 > balance Sheet > inventories
310550000
Annuals > 1 > balance Sheet > total Current Assets
4123737000
Annuals > 1 > balance Sheet > property Plant Equipment
22676000
Annuals > 1 > balance Sheet > total Assets
4542458000
Annuals > 1 > balance Sheet > payables
245557000
Annuals > 1 > balance Sheet > short Term Debt
4646000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
444951000
Annuals > 1 > balance Sheet > equity
4097507000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-425049000
Annuals > 1 > cash Flow > depreciation
111307000
Annuals > 1 > cash Flow > change In Working Capital
-308891000
Annuals > 1 > cash Flow > cash From Operations
-420327000
Annuals > 1 > cash Flow > capital Expenditures
43812000
Annuals > 1 > cash Flow > cash From Investing
308210000
Annuals > 1 > cash Flow > cash From Financing
1336727000
Annuals > 1 > cash Flow > net Change In Cash
1248104000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-5.161066312162186
Annuals > 1 > ratios > PB
11.390110262166727
Annuals > 1 > ratios > ROE
-7.200793067589635
Annuals > 1 > ratios > ROA
-6.495448059178532
Annuals > 1 > ratios > FCF
-464139000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.3784823813764152
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
410747000
Annuals > 2 > income Statement > cost Of Revenue
29431000
Annuals > 2 > income Statement > gross Profit
381315000
Annuals > 2 > income Statement > operating Expenses
1101656000
Annuals > 2 > income Statement > operating Income
-720341000
Annuals > 2 > income Statement > interest Expense
2193000
Annuals > 2 > income Statement > pretax Income
-729314000
Annuals > 2 > income Statement > net Income
-709594000
Annuals > 2 > income Statement > eps
-13.048564756072894
Annuals > 2 > income Statement > dividends Per Share
5467984
Annuals > 2 > income Statement > shares Outstanding
54381000
Annuals > 2 > income Statement > income Tax Expense
-19720000
Annuals > 2 > income Statement > EBITDA
-622779000
Annuals > 2 > income Statement > operating Margin
-175.3734050400855
Annuals > 2 > income Statement > total Other Income Expense Net
-8973000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
800740000
Annuals > 2 > balance Sheet > short Term Investments
1391808000
Annuals > 2 > balance Sheet > receivables
277275000
Annuals > 2 > balance Sheet > inventories
228353000
Annuals > 2 > balance Sheet > total Current Assets
2774198000
Annuals > 2 > balance Sheet > property Plant Equipment
16235000
Annuals > 2 > balance Sheet > total Assets
3134261000
Annuals > 2 > balance Sheet > payables
188721000
Annuals > 2 > balance Sheet > short Term Debt
3417000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
320562000
Annuals > 2 > balance Sheet > equity
2813699000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-720341000
Annuals > 2 > cash Flow > depreciation
104342000
Annuals > 2 > cash Flow > change In Working Capital
-375928000
Annuals > 2 > cash Flow > cash From Operations
-862807000
Annuals > 2 > cash Flow > capital Expenditures
103823000
Annuals > 2 > cash Flow > cash From Investing
-461184000
Annuals > 2 > cash Flow > cash From Financing
843757000
Annuals > 2 > cash Flow > net Change In Cash
-533936000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-13.048564756072894
Annuals > 2 > ratios > PB
15.778168514116116
Annuals > 2 > ratios > ROE
-25.21925763914335
Annuals > 2 > ratios > ROA
-22.639914161583864
Annuals > 2 > ratios > FCF
-966630000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-2.3533464638816595
Annuals > 2 > health Score
27
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
497277000
Annuals > 3 > income Statement > cost Of Revenue
580520000
Annuals > 3 > income Statement > gross Profit
497277000
Annuals > 3 > income Statement > operating Expenses
846023000
Annuals > 3 > income Statement > operating Income
-348746000
Annuals > 3 > income Statement > interest Expense
1096000
Annuals > 3 > income Statement > pretax Income
-399743000
Annuals > 3 > income Statement > net Income
-407626000
Annuals > 3 > income Statement > eps
-7.980773748923173
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
51076000
Annuals > 3 > income Statement > income Tax Expense
8522000
Annuals > 3 > income Statement > EBITDA
-392780000
Annuals > 3 > income Statement > operating Margin
-70.13113415661694
Annuals > 3 > income Statement > total Other Income Expense Net
-50997000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
1334676000
Annuals > 3 > balance Sheet > short Term Investments
1002052000
Annuals > 3 > balance Sheet > receivables
38221000
Annuals > 3 > balance Sheet > inventories
109076000
Annuals > 3 > balance Sheet > total Current Assets
2542971000
Annuals > 3 > balance Sheet > property Plant Equipment
15843000
Annuals > 3 > balance Sheet > total Assets
2850274000
Annuals > 3 > balance Sheet > payables
208850000
Annuals > 3 > balance Sheet > short Term Debt
3509000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
316050000
Annuals > 3 > balance Sheet > equity
2534224000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-348746000
Annuals > 3 > cash Flow > depreciation
4964000
Annuals > 3 > cash Flow > change In Working Capital
-340951000
Annuals > 3 > cash Flow > cash From Operations
-606812000
Annuals > 3 > cash Flow > capital Expenditures
121434000
Annuals > 3 > cash Flow > cash From Investing
-347070000
Annuals > 3 > cash Flow > cash From Financing
1119586000
Annuals > 3 > cash Flow > net Change In Cash
117873000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-7.980773748923173
Annuals > 3 > ratios > PB
16.45352349279306
Annuals > 3 > ratios > ROE
-16.084844907158956
Annuals > 3 > ratios > ROA
-14.301291735461222
Annuals > 3 > ratios > FCF
-728246000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-1.4644674899502692
Annuals > 3 > health Score
27
Valuation > metrics > PE
-
Valuation > metrics > PB
-
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
-
Profitability > metrics > ROA
-
Profitability > metrics > Net Margin
0.3054746348808876
Profitability > final Score
65
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
-
Risk > metrics > Interest Coverage
352.4370594159114
Risk > final Score
70
Risk > verdict
Low
Liquidity > metrics > Current Ratio
-
Liquidity > metrics > Quick Ratio
-
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
40
Prev Valuations > 1
70
Prev Valuations > 2
50
Prev Profitabilities > 0
51
Prev Profitabilities > 1
65
Prev Profitabilities > 2
91
Prev Risks > 0
100
Prev Risks > 1
70
Prev Risks > 2
100
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-22T10:29:08.376Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
6.1
Earnings History > 0 > eps Difference
-6.1
Earnings History > 0 > surprise Percent
-100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-30
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
5.18
Earnings History > 1 > eps Estimate
4.44
Earnings History > 1 > eps Difference
0.74
Earnings History > 1 > surprise Percent
16.6667
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-07-15
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
EUR
Earnings History > 2 > eps Actual
3.2572
Earnings History > 2 > eps Estimate
-0.99
Earnings History > 2 > eps Difference
4.2472
Earnings History > 2 > surprise Percent
429.0101
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-07
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
2.2732
Earnings History > 3 > eps Estimate
2.0546
Earnings History > 3 > eps Difference
0.2186
Earnings History > 3 > surprise Percent
10.6395
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-27
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
0.7125
Earnings History > 4 > eps Estimate
1.6979
Earnings History > 4 > eps Difference
-0.9854
Earnings History > 4 > surprise Percent
-58.0364
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-10-31
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
1.39
Earnings History > 5 > eps Estimate
0.03
Earnings History > 5 > eps Difference
1.36
Earnings History > 5 > surprise Percent
4533.3333
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-07-25
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
0.45
Earnings History > 6 > eps Estimate
-0.98
Earnings History > 6 > eps Difference
1.43
Earnings History > 6 > surprise Percent
145.9184
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-09
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-1.04
Earnings History > 7 > eps Estimate
-0.86
Earnings History > 7 > eps Difference
-0.18
Earnings History > 7 > surprise Percent
-20.9302
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-29
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-1.68
Earnings History > 8 > eps Estimate
-1.7
Earnings History > 8 > eps Difference
0.02
Earnings History > 8 > surprise Percent
1.1765
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-10-31
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-1.25
Earnings History > 9 > eps Estimate
-1.54
Earnings History > 9 > eps Difference
0.29
Earnings History > 9 > surprise Percent
18.8312
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-07-27
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-1.69
Earnings History > 10 > eps Estimate
-1.73
Earnings History > 10 > eps Difference
0.04
Earnings History > 10 > surprise Percent
2.3121
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-07
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.71
Earnings History > 11 > eps Estimate
-2.26
Earnings History > 11 > eps Difference
1.55
Earnings History > 11 > surprise Percent
68.5841
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-02
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.7
Earnings History > 12 > eps Estimate
-0.7
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
0
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-10-27
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-4.26
Earnings History > 13 > eps Estimate
-3.41
Earnings History > 13 > eps Difference
-0.85
Earnings History > 13 > surprise Percent
-24.9267
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-07-28
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-3.8
Earnings History > 14 > eps Estimate
-4.83
Earnings History > 14 > eps Difference
1.03
Earnings History > 14 > surprise Percent
21.3251
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-05
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-4.36
Earnings History > 15 > eps Estimate
-4.87
Earnings History > 15 > eps Difference
0.51
Earnings History > 15 > surprise Percent
10.4723
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-03
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-5.06
Earnings History > 16 > eps Estimate
-4.81
Earnings History > 16 > eps Difference
-0.25
Earnings History > 16 > surprise Percent
-5.1975
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-10-28
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-4.1
Earnings History > 17 > eps Estimate
-4.42
Earnings History > 17 > eps Difference
0.32
Earnings History > 17 > surprise Percent
7.2398
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-07-29
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
1.98
Earnings History > 18 > eps Estimate
-3.58
Earnings History > 18 > eps Difference
5.56
Earnings History > 18 > surprise Percent
155.3073
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-14
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
-0.67
Earnings History > 19 > eps Estimate
-2.59
Earnings History > 19 > eps Difference
1.92
Earnings History > 19 > surprise Percent
74.1313
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-04
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
-3.53
Earnings History > 20 > eps Estimate
-2.64
Earnings History > 20 > eps Difference
-0.89
Earnings History > 20 > surprise Percent
-33.7121
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-10-22
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
-3.39
Earnings History > 21 > eps Estimate
-2.39
Earnings History > 21 > eps Difference
-1
Earnings History > 21 > surprise Percent
-41.841
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-07-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
-2.86
Earnings History > 22 > eps Estimate
-2.33
Earnings History > 22 > eps Difference
-0.53
Earnings History > 22 > surprise Percent
-22.7468
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-14
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
-1.87
Earnings History > 23 > eps Estimate
-1.72
Earnings History > 23 > eps Difference
-0.15
Earnings History > 23 > surprise Percent
-8.7209
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-02-29
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
-2.37
Earnings History > 24 > eps Estimate
-1.38
Earnings History > 24 > eps Difference
-0.99
Earnings History > 24 > surprise Percent
-71.7391
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-10-24
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
-0.66
Earnings History > 25 > eps Estimate
-1.17
Earnings History > 25 > eps Difference
0.51
Earnings History > 25 > surprise Percent
43.5897
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-01
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
EUR
Earnings History > 26 > eps Actual
-1.37
Earnings History > 26 > eps Estimate
-0.82
Earnings History > 26 > eps Difference
-0.55
Earnings History > 26 > surprise Percent
-67.0732
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-05-09
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
EUR
Earnings History > 27 > eps Actual
0.17
Earnings History > 27 > eps Estimate
-0.74
Earnings History > 27 > eps Difference
0.91
Earnings History > 27 > surprise Percent
122.973
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-02-28
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
EUR
Earnings History > 28 > eps Actual
-0.9
Earnings History > 28 > eps Estimate
-0.65
Earnings History > 28 > eps Difference
-0.25
Earnings History > 28 > surprise Percent
-38.4615
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-10-25
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
EUR
Earnings History > 29 > eps Actual
-0.51
Earnings History > 29 > eps Estimate
-0.68
Earnings History > 29 > eps Difference
0.17
Earnings History > 29 > surprise Percent
25
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-08-02
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
EUR
Earnings History > 30 > eps Actual
-0.07
Earnings History > 30 > eps Estimate
-0.47
Earnings History > 30 > eps Difference
0.4
Earnings History > 30 > surprise Percent
85.1064
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-05-09
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
BeforeMarket
Earnings History > 31 > currency
EUR
Earnings History > 31 > eps Actual
-0.55
Earnings History > 31 > eps Estimate
-0.38
Earnings History > 31 > eps Difference
-0.17
Earnings History > 31 > surprise Percent
-44.7368
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-03-01
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
BeforeMarket
Earnings History > 32 > currency
EUR
Earnings History > 32 > eps Actual
-0.41
Earnings History > 32 > eps Estimate
-0.35
Earnings History > 32 > eps Difference
-0.06
Earnings History > 32 > surprise Percent
-17.1429
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-10-26
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
BeforeMarket
Earnings History > 33 > currency
EUR
Earnings History > 33 > eps Actual
-0.41
Earnings History > 33 > eps Estimate
-0.34
Earnings History > 33 > eps Difference
-0.07
Earnings History > 33 > surprise Percent
-20.5882
Earnings History > 34 > period
2017-06-30
Earnings History > 34 > report Date
2017-08-24
Earnings History > 34 > date
2017-06-30
Earnings History > 34 > before After Market
BeforeMarket
Earnings History > 34 > currency
EUR
Earnings History > 34 > eps Actual
0.01
Earnings History > 34 > eps Estimate
-0.37
Earnings History > 34 > eps Difference
0.38
Earnings History > 34 > surprise Percent
102.7027
Earnings History > 35 > period
2017-03-31
Earnings History > 35 > report Date
2017-05-02
Earnings History > 35 > date
2017-03-31
Earnings History > 35 > before After Market
AfterMarket
Earnings History > 35 > currency
EUR
Earnings History > 35 > eps Actual
-0.4408
Earnings History > 35 > eps Estimate
-
Earnings History > 35 > eps Difference
0
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2016-12-31
Earnings History > 36 > report Date
2017-03-15
Earnings History > 36 > date
2016-12-31
Earnings History > 36 > before After Market
BeforeMarket
Earnings History > 36 > currency
EUR
Earnings History > 36 > eps Actual
-0.4926
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-09-30
Earnings History > 37 > report Date
2016-10-27
Earnings History > 37 > date
2016-09-30
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
EUR
Earnings History > 37 > eps Actual
-0.2576
Earnings History > 37 > eps Estimate
0
Earnings History > 37 > eps Difference
-0.2576
Earnings History > 37 > surprise Percent
-
argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYGART and VYGART HYTRULO to treat generalized myasthenia gravis (gMG), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgartigimod for the treatment of seronegative and ocular gMG, thyroid eye diseases, ITP, myositis, Sjögren's disease, lupus nephropathy, systemic sclerosis, antibody-mediated rejection, and autoimmune encephalitis; empasiprubart for multifocal motor neuropath, CIDP, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome, amyotrophic lateral sclerosis, and spinal muscular atrophy. In addition, the company is also developing ARGX-119, a MuSK agonist to treat congenital myasthenic syndromes and amyotrophic lateral sclerosis; ARGX-109, which targets IL-6 to treat inflammation; ARGX-121 and ARGX 220 that targets the immune system; ARGX-213, which targets FcRn; and ARGX-118, which develops antibodies against Galectin-10, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It has strategic collaborations with OncoVerity, Inc, LEO Pharma A/S, Zai Lab Limited, AbbVie, Inc., Elektrofi, Genmab SE, Chugai Pharmaceutical Co., Ltd., Clayton Foundation, Halozyme Therapeutics, Inc., AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Lonza Sales AG, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, and IQVIA Ltd. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$1016.4751
Analyst Picks
Strong Buy
14
Buy
7
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Low
Low ≥ 50
High ≤ 10
* Institutions hold a combined 58.91% of the total shares of argenx NV ADR
1.
FMR Inc(8.862%)
since
2025/06/30
2.
T. Rowe Price Associates, Inc.(8.1372%)
since
2025/06/30
3.
HHG PLC(4.1918%)
since
2025/06/30
4.
Artisan Partners Limited Partnership(3.8395%)
since
2025/06/30
5.
Capital World Investors(3.188%)
since
2025/06/30
6.
venBio Select Advisor LLC(1.9199%)
since
2025/06/30
7.
American Funds EUPAC A(1.8239%)
since
2025/06/30
8.
Capital Group EUPAC Composite(1.8239%)
since
2025/06/30
9.
Fidelity Growth Compy Commingled Pl S(1.4224%)
since
2025/07/31
10.
Citadel Advisors Llc(1.415%)
since
2025/06/30
11.
ClearBridge Advisors, LLC(1.2629%)
since
2025/06/30
12.
T. Rowe Price Health Sciences(1.15%)
since
2025/07/31
13.
RTW INVESTMENTS, LLC(1.1005%)
since
2025/06/30
14.
US Small-Cap Growth II Equity Comp(1.0201%)
since
2025/06/30
15.
Fidelity Growth Company Fund(1.0185%)
since
2025/07/31
16.
BB Biotech AG Ord(0.9657%)
since
2024/12/31
17.
Janus Concentrated Growth CF(0.9359%)
since
2025/06/30
18.
Janus Henderson Forty S(0.9359%)
since
2025/06/30
19.
Bellevue Group AG(0.9331%)
since
2025/06/30
20.
T. Rowe Price US Growth Stock Composite(0.903%)
since
2025/06/30
21.
BlackRock Inc(0.8989%)
since
2025/06/30
22.
T. Rowe Price New Horizons(0.8924%)
since
2025/07/31
23.
Fidelity OTC(0.8053%)
since
2025/07/31
24.
T. Rowe Price Growth Stock Tr-B(0.728%)
since
2025/06/30
25.
Millennium Management LLC(0.7024%)
since
2025/06/30
26.
Morgan Stanley - Brokerage Accounts(0.7015%)
since
2025/06/30
27.
Capital Group New Economy Comp(0.67%)
since
2025/06/30
28.
American Funds New Economy A(0.67%)
since
2025/06/30
29.
Wellington Management Company LLP(0.6623%)
since
2025/06/30
30.
Bank of America Corp(0.5492%)
since
2025/06/30
31.
SEI Investments Co(0.517%)
since
2025/06/30
32.
T. Rowe Price Growth Stock(0.5155%)
since
2025/07/31
33.
Janus Inst Mid Cap Growth CF(0.51%)
since
2025/06/30
34.
Janus Henderson Enterprise D(0.51%)
since
2025/06/30
35.
Adage Capital Partners Gp LLC(0.4855%)
since
2025/06/30
36.
Artisan U.S. Mid-Cap Growth(0.475%)
since
2025/06/30
37.
Artisan Mid Cap Investor(0.475%)
since
2025/06/30
38.
Franklin Resources Inc(0.4572%)
since
2025/06/30
39.
Jennison Associates LLC(0.4324%)
since
2025/06/30
40.
Amvescap Plc.(0.3983%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
6.1
Date
2025-09-30
EPS Actual
5.18
EPS Estimate
4.44
EPS Difference
0.74
Surprise Percent
16.6667%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.